Ticker > Company >

Guj. Terce Lab share price

Gujarat Terce Laboratories Ltd.

BSE: 524314 SECTOR: Pharmaceuticals & Drugs  11.8 K   13   0

50.48
+1.33 (2.71%)
BSE: Today, 03:32 PM

Price Summary

Today's High

₹ 50.99

Today's Low

₹ 48.03

52 Week High

₹ 94.9

52 Week Low

₹ 45.15

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

37.46 Cr.

Enterprise Value

37.62 Cr.

No. of Shares

0.74 Cr.

P/E

0

P/B

6.11

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.26

CASH

0.78 Cr.

DEBT

0.94 Cr.

Promoter Holding

37.03 %

EPS (TTM)

₹  -1.32

Sales Growth

4.63%

ROE

-14.79 %

ROCE

41.39%

Profit Growth

-501.93 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Gujarat Terce Laboratories Ltd.

Vitfol Acolate Resplash Aziter Codimol TerfloraZ Tynol fungibeat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.63%
3 Year7.74%
5 Year5.98%

Profit Growth

1 Year-501.93%
3 Year-203.91%
5 Year-228.79%

ROE%

1 Year-14.79%
3 Year-11.01%
5 Year-9.82%

ROCE %

1 Year41.39%
3 Year12.1%
5 Year5.64%

Debt/Equity

0.1537

Price to Cash Flow

12.24

Interest Cover Ratio

9.1618

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 37.03 0.00
Mar 2025 37.03 0.00
Dec 2024 37.03 0.00
Sep 2024 37.03 0.00
Jun 2024 37.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.9247 Cr.
  • Company has a healthy Interest coverage ratio of 9.1618.
  • The company has an efficient Cash Conversion Cycle of -20.5968 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 29.8685004396116.

 Limitations

  • The company has shown a poor profit growth of -203.91093163918% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.74174516494512% for the Past 3 years.
  • Company has a poor ROE of -11.006% over the past 3 years.
  • The company has a low EBITDA margin of -0.490609591098196% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 12.21 11.89 13.3 12.68 12.32
Total Expenditure 11.2 11.81 11.64 11.59 11.27
Operating Profit 1 0.08 1.66 1.09 1.05
Other Income 0.08 0.07 0.08 0.07 0.09
Interest 0.15 0.13 0.13 0.08 0.07
Depreciation 0.09 0.09 0.09 0.1 0.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.84 -0.07 1.52 0.98 0.97
Tax 0.3 0.01 0.03 -0.03 4.36
Profit After Tax 0.54 -0.08 1.48 1.01 -3.39
Adjusted EPS (Rs) 0.73 -0.1 2 1.36 -4.57

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 25.18 40.13 46.78 47.97 50.2
Total Expenditure 27.95 39.02 48.95 46.71 46.31
Operating Profit -2.77 1.12 -2.16 1.27 3.88
Other Income 0.8 0.31 0.35 0.32 0.31
Interest 0.39 0.4 0.72 0.68 0.42
Depreciation 0.18 0.28 0.36 0.37 0.38
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.53 0.75 -2.89 0.54 3.39
Tax -0.01 -0.13 -1.22 0.3 4.37
Net Profit -2.52 0.87 -1.67 0.24 -0.98
Adjusted EPS (Rs.) -3.4 1.18 -2.25 0.33 -1.32

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 7.42 7.42 7.42 7.42 7.42
Total Reserves 0.24 1.11 -0.56 -0.31 -0.94
Borrowings 0.42 2.3 1.46 0.93 0.3
Other N/C liabilities 1.9 3.04 2.07 1.88 2.98
Current liabilities 11.71 13.21 16.61 12.14 12.64
Total Liabilities 21.7 27.09 27 22.05 22.39
Assets
Net Block 2.45 4.29 3.99 3.69 3.65
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.27 0.27 0.27 0.27 0
Loans & Advances 2.55 2.65 2.29 2.46 2.31
Other N/C Assets 4.4 4.4 4.4 4.4 4.4
Current Assets 12.02 15.48 16.05 11.22 12.02
Total Assets 21.7 27.09 27 22.05 22.39
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -2.52 0.75 -2.89 0.54 3.39
Adjustment 0.57 0.6 1.02 0.76 0.53
Changes in Assets & Liabilities 1.94 -1.69 1.94 1.29 -0.78
Tax Paid -0.15 -0.1 -0.04 0 -0.08
Operating Cash Flow -0.16 -0.44 0.03 2.6 3.06
Investing Cash Flow -0.42 -2.37 0.62 -0.46 0.46
Financing Cash Flow 1.83 1.53 -0.12 -4.08 -2.83
Net Cash Flow 1.24 -1.28 0.52 -1.94 0.69

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 37.03 37.03 37.03 37.03 37.03
aalap natubhai prajapati 0.72 0.72 13.22 13.22 13.22
abundant trade link priva... 14.50 14.50 14.50 14.50 14.50
amritbhai p. prajapati 0.42 0.42 0.42 0.42 0.42
natwarbhai parsottam praj... 8.57 8.57 8.57 8.57 8.57
shachi ravi oza 0.10 0.10 0.10 0.10 0.10
shobhanaben natvarbhai pr... 0.22 0.22 0.22 0.22 0.22
prajapati manjulaben s 12.49 12.49 - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 62.97 62.97 62.97 62.97 62.97
dheeraj kumar lohia 1.34 1.34 1.26 1.21 1.21
rishabh negi 1.01 1.01 1.01 1.01 1.01
sagar saxena 1.11 1.21 1.21 1.21 1.39

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY22
Presentation Q1FY25

Company News

Guj. Terce Lab - Quaterly Results 26 May, 8:58 PM Guj. Terce Lab - Quaterly Results 26 May, 8:58 PM Gujarat Terce Laboratories informs about closure of trading window 25 Mar, 12:44 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Guj. Terce Lab - Quaterly Results 4 Feb, 4:59 PM Gujarat Terce Laboratories informs about board meeting 27 Jan, 12:55 PM Gujarat Terce Laboratories informs about disclosure 21 Nov, 11:19 AM Gujarat Terce Laboratories informs about disclosure 30 Oct, 5:36 PM Gujarat Terce Laboratories informs about disclosures 30 Oct, 5:34 PM Gujarat Terce Laboratories informs about disclosures 30 Oct, 5:27 PM Guj. Terce Lab - Quaterly Results 30 Oct, 3:16 PM Guj. Terce Lab - Quaterly Results 30 Oct, 3:16 PM Gujarat Terce Laboratories informs about board meeting 18 Oct, 11:04 AM GujaratTerce Laboratories informs about closure of trading window 26 Sep, 9:51 AM Gujarat Terce Laboratories informs about press release 31 Aug, 12:15 PM Gujarat Terce Laboratories informs about annual report 24 Aug, 3:20 PM Gujarat Terce Laboratories informs about annual report 24 Aug, 12:29 PM Gujarat Terce Laboratories informs about issuance of duplicate share certificate 21 Aug, 9:43 AM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Guj. Terce Lab - Quaterly Results 9 Aug, 5:22 PM Gujarat Terce Laboratories informs about certificate 8 Jul, 11:11 AM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Guj. Terce Lab - Quaterly Results 5 Feb, 4:51 PM Gujarat Terce Laboratories informs about loss of share certificate 5 Jan, 4:10 PM Gujarat Terce Laboratories informs about loss of share certificate 3 Jun, 3:58 PM Guj. Terce Lab - Quaterly Results 13 May, 7:17 PM Guj. Terce Lab - Quaterly Results 13 May, 7:17 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Guj. Terce Lab - Quaterly Results 31 Jan, 5:40 PM Gujarat Terce Laboratories informs about RPT disclosure 25 Nov, 5:08 PM Gujarat Terce Laboratories informs about resignation of CS cum CO 6 Sep, 5:04 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Guj. Terce Lab - Quaterly Results 5 Aug, 5:18 PM Gujarat Terce Laboratories informs about board meeting 27 Jul, 12:22 PM Gujarat Terce Laboratories informs about compliance certificate 7 Jul, 4:50 PM Gujarat Terce Laboratories informs about compliance certificate 14 Apr, 10:39 AM Gujarat Terce Laboratories informs about outcome of board meeting 24 Jan, 2:47 PM Guj. Terce Lab - Quaterly Results 24 Jan, 12:23 PM Gujarat Terce Laboratories informs about typographical error in financial results 29 Jul, 12:22 PM Gujarat Terce Laboratories informs about non-applicability of large corporate entity 19 Jul, 12:18 PM Gujarat Terce Laboratories informs about clerical error 2 Jul, 3:55 PM Gujarat Terce Laboratories informs about board meeting 18 Jun, 1:53 PM Gujarat Terce Laboratories informs about outcome of board meeting 7 Nov, 3:23 PM Gujarat Terce Laboratories informs about certificate 9 Oct, 3:03 PM

Guj. Terce Lab Stock Price Analysis and Quick Research Report. Is Guj. Terce Lab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Guj. Terce Lab and its performance over the period of time. Guj. Terce Lab stock price today is Rs 50.48.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Guj. Terce Lab cash from the operating activity was Rs 3.0591 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Guj. Terce Lab has a Debt to Equity ratio of 0.1537 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Guj. Terce Lab , the EPS growth was -501.8586 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Guj. Terce Lab has OPM of 7.73500255004463 % which is a bad sign for profitability.
     
  • ROE: Guj. Terce Lab have a poor ROE of -14.791 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Guj. Terce Lab is Rs 50.48. One can use valuation calculators of ticker to know if Guj. Terce Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Guj. Terce Lab
X